Faecalibacterium prausnitzii — Hermetica Encyclopedia
Probiotic & Fiber · Fermented/Probiotic

Faecalibacterium prausnitzii

Moderate Evidenceprobiotic3 PubMed Studies

Hermetica Superfood Encyclopedia

The Short Answer

Faecalibacterium prausnitzii is a beneficial gut bacterium that produces butyrate, a short-chain fatty acid crucial for maintaining intestinal barrier integrity and reducing inflammation. This next-generation probiotic modulates immune responses and supports colon health through direct anti-inflammatory mechanisms.

3
PubMed Studies
1
Validated Benefits
Synergy Pairings
At a Glance
CategoryProbiotic & Fiber
GroupFermented/Probiotic
Evidence LevelModerate
Primary KeywordFaecalibacterium prausnitzii benefits
Synergy Pairings4
Faecalibacterium prausnitzii close-up macro showing natural texture and detail — rich in anti-inflammatory, short-chain fatty acid producer, immunomodulatory
Faecalibacterium prausnitzii — botanical close-up

Health Benefits

Supports gut health by producing butyrate, a short-chain fatty acid essential for colon health. This helps maintain a healthy gut lining. - Reduces inflammation by modulating immune responses, decreasing the risk of inflammatory bowel diseases. - Enhances digestive efficiency by breaking down complex carbohydrates, improving nutrient absorption. - Boosts immune health by increasing the production of anti-inflammatory cytokines, which protect against infections. - Promotes mental well-being by influencing the gut-brain axis, potentially reducing anxiety and depression. - Aids in weight management by regulating fat storage and energy expenditure, supporting a healthy body weight. - Improves skin health by reducing systemic inflammation, which can alleviate conditions like acne and eczema.

Origin & History

Faecalibacterium prausnitzii growing in natural environment — natural habitat
Natural habitat

Faecalibacterium prausnitzii is a gram-positive anaerobic bacterium commonly found in the human gut microbiota. It is cultivated in specialized anaerobic conditions due to its sensitivity to oxygen. This bacterium is typically isolated from human fecal samples for research and probiotic development.

Faecalibacterium prausnitzii was first identified in the late 20th century as a prominent member of the human gut microbiota. Its importance in gut health has been recognized more recently, leading to increased scientific interest.Traditional Medicine

Scientific Research

Research on Faecalibacterium prausnitzii includes in vitro and animal studies, with emerging human trials focusing on its role in gut health and inflammation. Some studies suggest its potential in managing inflammatory bowel disease.

Preparation & Dosage

Faecalibacterium prausnitzii traditionally prepared — pairs with Inulin, Resistant Starch, Omega-3 Fatty Acids
Traditional preparation

Currently, there is no standardized dosage for Faecalibacterium prausnitzii as a supplement. Consult a healthcare provider before use.

Nutritional Profile

- Produces butyrate, a key short-chain fatty acid. - Contains enzymes that help break down complex carbohydrates. - Rich in polysaccharides that support gut health.

How It Works

Mechanism of Action

F. prausnitzii produces butyrate through the fermentation of dietary fiber, which serves as the primary energy source for colonocytes and maintains tight junction integrity. Butyrate activates GPR43 and GPR109A receptors, triggering anti-inflammatory pathways and regulatory T-cell differentiation. The bacterium also produces other metabolites like propionate and acetate that modulate immune responses and strengthen the intestinal barrier.

Clinical Evidence

Clinical studies have consistently shown F. prausnitzii depletion in inflammatory bowel disease patients, with levels inversely correlating with disease severity. Small-scale intervention trials (n=20-50) demonstrate that F. prausnitzii supplementation can increase fecal butyrate levels by 40-60% within 4 weeks. Observational studies in IBD patients show 3-5 fold reductions in F. prausnitzii abundance compared to healthy controls. However, large-scale randomized controlled trials are still limited, and most evidence comes from observational and mechanistic studies.

Safety & Interactions

F. prausnitzii is generally considered safe as it's a naturally occurring commensal bacterium in healthy human gut microbiomes. No significant adverse effects have been reported in clinical studies, though mild gastrointestinal symptoms like bloating may occur initially. The bacterium may theoretically interact with immunosuppressive medications used in IBD treatment, though specific interactions haven't been documented. Pregnant and breastfeeding women should consult healthcare providers before supplementation due to limited safety data in these populations.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Faecalibacterium prausnitziiF. prausnitziiFusobacterium prausnitziiBacteroides prausnitziiButyrate-producing bacteriumAnti-inflammatory probioticGut barrier protector

Frequently Asked Questions

What foods increase Faecalibacterium prausnitzii naturally?
High-fiber foods like oats, barley, Jerusalem artichokes, and resistant starch from cooled potatoes and rice promote F. prausnitzii growth. Polyphenol-rich foods including berries, green tea, and pomegranates also support this beneficial bacterium through prebiotic effects.
How long does it take for Faecalibacterium prausnitzii to colonize the gut?
Studies show detectable increases in F. prausnitzii levels within 2-4 weeks of targeted supplementation or dietary intervention. However, stable colonization and optimal butyrate production typically requires 8-12 weeks of consistent support through fiber intake or probiotic supplementation.
Can Faecalibacterium prausnitzii help with Crohn's disease?
Research shows F. prausnitzii levels are significantly reduced in Crohn's disease patients, and higher levels correlate with better disease outcomes. Small clinical trials suggest supplementation may help reduce inflammation markers and improve symptoms, though larger studies are needed to confirm therapeutic benefits.
What kills Faecalibacterium prausnitzii in the gut?
Antibiotics, particularly broad-spectrum ones, significantly reduce F. prausnitzii populations and can take months to recover. High-fat, low-fiber diets, chronic stress, NSAIDs, and proton pump inhibitors also negatively impact F. prausnitzii abundance in the gut microbiome.
Is Faecalibacterium prausnitzii available as a supplement?
F. prausnitzii supplements are emerging but remain limited due to the bacterium's strict anaerobic requirements and difficulty in cultivation. Most available products contain spore-forming or freeze-dried preparations, though effectiveness varies significantly between formulations and manufacturers.
Is Faecalibacterium prausnitzii safe for people with IBS or sensitive digestion?
Faecalibacterium prausnitzii is generally considered safe and beneficial for IBS sufferers, as it produces butyrate that strengthens the gut barrier and reduces inflammation. However, some individuals may experience temporary mild bloating or gas during initial colonization as the bacteria establish themselves. It's advisable to start with lower doses and gradually increase to minimize adjustment symptoms, and consult a healthcare provider if you have severe IBS or compromised immune function.
How does Faecalibacterium prausnitzii compare to other common probiotic strains like Lactobacillus or Bifidobacterium?
While Lactobacillus and Bifidobacterium are common probiotics that support general gut health, Faecalibacterium prausnitzii is uniquely specialized in producing butyrate, which directly fuels colon cells and has stronger anti-inflammatory effects. Faecalibacterium prausnitzii is considered a 'keystone' species because low levels are specifically associated with inflammatory bowel diseases, making it particularly valuable for individuals with IBD or chronic inflammation. Combining it with other probiotic strains may provide complementary benefits, as different strains target different aspects of gut health.
What clinical evidence exists for Faecalibacterium prausnitzii's effectiveness in improving gut health?
Research shows that people with Crohn's disease and ulcerative colitis have significantly lower levels of Faecalibacterium prausnitzii compared to healthy individuals, establishing a strong correlation with inflammatory bowel disease. Studies demonstrate that increasing this bacteria improves intestinal barrier function, reduces inflammatory markers, and enhances butyrate production in the colon. While preliminary human trials show promise, most evidence comes from in-vitro and animal studies, so larger clinical trials are still needed to establish definitive dosing and efficacy in supplement form.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.